FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Audino Podda

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Co-author Network

Publications

TOP 3
Pierre Van Damme; Rana M Qasim Khan; Simona Rondini; Allan Saul; Alessandra Anemona; Venere Basile; Ilse De Coster; Vito Di Cioccio; Anne Katrin Hilbert; Froukje Kafeja; Elisa Marchetti; Laura B Martin; Francesca Micoli; Audino Podda
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults.
Audino Podda; Allan James Saul; Rashmi Arora; Zulfiqar Bhutta; Anju Sinha; Rajni Gaind; Tanu Singhal; Samir Saha; W Abdullah Brooks; Laura B Martin; Yeshwant Amdekar; Amar Jeet Chitkara; Mae Shieh; Ambujam Nair Kapur; Tulsi Das Chugh
Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009.
Arvydas Ambrozaitis; Nicola Groth; Roberto Bugarini; Vittoria Sparacio; Audino Podda; Maria Lattanzi
A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Audino Podda (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Pierre Van Damme; Rana M Qasim Khan; Simona Rondini; Allan Saul; Alessandra Anemona; Venere Basile; Ilse De Coster; Vito Di Cioccio; Anne Katrin Hilbert; Froukje Kafeja; Elisa Marchetti; Laura B Martin; Francesca Micoli; Audino Podda
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults.
PloS one 2011;6(9):e25398.
2010: Audino Podda; Allan James Saul; Rashmi Arora; Zulfiqar Bhutta; Anju Sinha; Rajni Gaind; Tanu Singhal; Samir Saha; W Abdullah Brooks; Laura B Martin; Yeshwant Amdekar; Amar Jeet Chitkara; Mae Shieh; Ambujam Nair Kapur; Tulsi Das Chugh
Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009.
Journal of infection in developing countries 2010;4(6):404-11.
2009: Arvydas Ambrozaitis; Nicola Groth; Roberto Bugarini; Vittoria Sparacio; Audino Podda; Maria Lattanzi
A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine.
Vaccine 2009;27(43):6022-9.
2009: Agnieszka Szymczakiewicz-Multanowska; Nicola Groth; Roberto Bugarini; Maria Lattanzi; Daniela Casula; Anne Hilbert; Theodore Tsai; Audino Podda
Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.
The Journal of infectious diseases 2009;200(6):841-8.
2009: Timo Vesikari; Michele Pellegrini; Aino Karvonen; Nicola Groth; Astrid Borkowski; Derek T O'Hagan; Audino Podda
Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
The Pediatric infectious disease journal 2009;28(7):563-71.
2009: Angelika Banzhoff; Roberto Gasparini; Franco Laghi Pasini; Tommaso Staniscia; Paolo Durando; Emanuele Montomoli; Pier Leopoldo Capecchi; Pamela Capecchi; Pamela di Giovanni; Laura Sticchi; Chiara Gentile; Anke Hilbert; V F H Brauer; Sandrine Tilman; Audino Podda
MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults.
PloS one 2009;4(2):e4384.
2008: Angelika Banzhoff; Michele Pellegrini; Giuseppe Del Giudice; Elena Fragapane; Nicola Groth; Audino Podda
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
Influenza and other respiratory viruses 2008;2(6):243-9.
2008: Paolo Durando; Daniela Fenoglio; Antonio Boschini; Filippo Ansaldi; Giancarlo Icardi; Laura Sticchi; A Renzoni; P Fabbri; Alessandra Ferrera; A Parodi; Bianca Bruzzone; Giovanni Gabutti; Audino Podda; Giuseppe Del Giudice; Elena Fragapane; Francesco Indiveri; Pietro Crovari; Roberto Gasparini
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.
Clinical and vaccine immunology : CVI 2008;15(2):253-9.
2008: Rongcheng Li; Hanhua Fang; Yanping Li; Youping Liu; Michele Pellegrini; Audino Podda
Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects.
Immunity & ageing : I & A 2008;5():2.
2006: Giuseppe Del Giudice; Elena Fragapane; Roberto Bugarini; Maninder Hora; Thomas Henriksson; Emanuela Palla; Derek O'Hagan; John Donnelly; Rino Rappuoli; Audino Podda
Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.
Clinical and vaccine immunology : CVI 2006;13(9):1010-3.
2006: Iain Stephenson; Maria C Zambon; Anna Rudin; Anthony Colegate; Audino Podda; Roberto Bugarini; Giuseppe Del Giudice; Ada Minutello; Susan Bonnington; Jan Holmgren; Kingston H G Mills; Karl G Nicholson
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
Journal of virology 2006;80(10):4962-70.
2006: Giuseppe Del Giudice; Anne Katrin Hilbert; Roberto Bugarini; Ada Minutello; Olga Popova; daniela toneatto; Ines Schoendorf; Astrid Borkowski; Rino Rappuoli; Audino Podda
An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
Vaccine 2006;24(16):3063-5.
2005: Iain Stephenson; Roberto Bugarini; Karl G Nicholson; Audino Podda; John M Wood; Maria C Zambon; Jacqueline M Katz
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.
The Journal of infectious diseases 2005;191(8):1210-5.
2004: Edel A McNeela; Inderjit Jabbal-Gill; Lisbeth Illum; Mariagrazia Pizza; Rino Rappuoli; Audino Podda; David J M Lewis; Kingston H G Mills
Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan.
Vaccine 2004;22(8):909-14.
2004: Maila J Matjila; Thabo C Phohu; Angelika Banzhoff; Simonetta Viviani; Anwar A Hoosen; Massimo Bianchini; Pantaleo Nacci; Chapman W Palweni; Audino Podda; Michael Whitfield; Sanet Aspinall
Safety and immunogenicity of two Haemophilus influenzae type b conjugate vaccines.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2004;94(1):43-6.
2003: Sharon Frey; Gregory Poland; Sandra Percell; Audino Podda
Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults.
Vaccine 2003;21(27-30):4234-7.
2003: Alfonso Iorio; Daniela Francisci; Barbara Camilloni; Giuliano Stagni; Matteo De Martino; daniela toneatto; Roberto Bugarini; Mariella Neri; Audino Podda
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy.
Vaccine 2003;21(25-26):3629-37.
2003: Güler Kanra; Simonetta Viviani; Kadriye Yurdakök; Emin Ozmert; Alessandra Anemona; Songül Yalçin; Okan Demiralp; Nihan Bilgili; Ates Kara; A Bülent Cengiz; Belgin Mutlu; Alexandra Baldini; Elisa Marchetti; Audino Podda
Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine.
Pediatrics international : official journal of the Japan Pediatric Society 2003;45(3):314-8.
2003: Angelika Banzhoff; Pantaleo Nacci; Audino Podda
A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis.
Gerontology 2003;49(3):177-84.
2003: Iain Stephenson; Karl G Nicholson; Anthony Colegate; Audino Podda; John Wood; Ellen Ypma; Maria Zambon
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population.
Vaccine 2003;21(15):1687-93.
2003: Samuele Peppoloni; Paolo Ruggiero; Mario Contorni; Maurizio Morandi; Mariagrazia Pizza; Rino Rappuoli; Audino Podda; Giuseppe Del Giudice
Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines.
Expert review of vaccines 2003;2(2):285-93.
2003: Audino Podda; Giuseppe Del Giudice
MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.
Expert review of vaccines 2003;2(2):197-203.
2003: Kingston H G Mills; Catherine Cosgrove; Edel A McNeela; Amy Sexton; Rafaela Giemza; Inderjit Jabbal-Gill; Anne Church; Wu Lin; Lisbeth Illum; Audino Podda; Rino Rappuoli; Mariagrazia Pizza; George E Griffin; David J M Lewis
Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a.
Infection and immunity 2003;71(2):726-32.
2002: John M Wood; Karl G Nicholson; Iain Stephenson; Maria Zambon; Robert W Newman; Diane Major; Audino Podda
Experience with the clinical development of influenza vaccines for potential pandemics.
Medical microbiology and immunology 2002;191(3-4):197-201.
2001: Giuseppe Del Giudice; Audino Podda; Rino Rappuoli
What are the limits of adjuvanticity?
Vaccine 2001;20 Suppl 1():S38-41.
2001: Karl G Nicholson; Anthony Colegate; Audino Podda; Iain Stephenson; J Wood; Ellen Ypma; Maria C Zambon
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
Lancet 2001;357(9272):1937-43.
2001: Audino Podda
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine.
Vaccine 2001;19(17-19):2673-80.
2001: Roberto Gasparini; T Pozzi; EMANUELE MONTOMOLI; Elena Fragapane; F Senatore; M Minutello; Audino Podda
Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects.
European journal of epidemiology 2001;17(2):135-40.
2000: M Minutello; Carla Zotti; S Orecchia; E Di Martino; I Bastianoni; Ellen Ypma; A Ruggenini Moiraghi; Audino Podda
Dose range evaluation of a new inactivated hepatitis A vaccine administered as a single dose followed by a booster.
Vaccine 2000;19(1):10-5.
1999: Güler Kanra; Simonetta Viviani; Kadriye Yurdakök; Emin Ozmert; Songül Yalçin; A Baldini; B Mutlu; Ates Kara; Mehmet Ceyhan; Audino Podda
Safety, tolerability and immunogenicity of a Haemophilus influenzae type b vaccine containing aluminum phosphate adjuvant administered at 2, 3 and 4 months of age.
The Turkish journal of pediatrics 1999;41(4):421-7.
1999: S De Donato; DM Granoff; M Minutello; G Lecchi; M Faccini; M Agnello; F Senatore; P Verweij; B Fritzell; Audino Podda
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly.
Vaccine 1999;17(23-24):3094-101.
1999: M Minutello; F Senatore; G Cecchinelli; M Bianchi; T Andreani; Audino Podda; P Crovari
Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons.
Vaccine 1999;17(2):99-104.
1997: A Di Tommaso; M Bartalini; Samuele Peppoloni; Audino Podda; Rino Rappuoli; Maria Teresa De Magistris
Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.
Vaccine 1997;15(11):1218-24.